- Home
- AIOS vs ABVC Comparison
AIOS vs ABVC Comparison
Compare AIOS & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIOS | ABVC |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | China | United States |
| Employees | 20 | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.8M | 34.6M |
| IPO Year | 2014 | 2009 |
Fundamental Metrics
Financial Performance| Metric | AIOS | ABVC |
|---|---|---|
| Price | $13.57 | $0.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 22.4K | ★ 101.5K |
| Earning Date | 04-20-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.14 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $509,589.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.39 | $0.82 |
| 52 Week High | $33.87 | $3.39 |
Technical Indicators
Market Signals| Indicator | AIOS | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 53.64 | 37.11 |
| Support Level | $13.01 | N/A |
| Resistance Level | $16.24 | $1.14 |
| Average True Range (ATR) | 1.43 | 0.09 |
| MACD | 0.25 | 0.00 |
| Stochastic Oscillator | 53.23 | 22.38 |
Price Performance
Historical ComparisonAbout AIOS AIOS Tech Inc. Class A Common Shares
AIOS Tech Inc is a provider of artificial intelligence and technology-driven professional services. The Company is focused on delivering information technology solutions, data services, and artificial intelligence-powered offerings to a diverse commercial client base. Its core businesses include digital transformation services, tailored IT solutions for the financial sector, enterprise data solutions, and the development of AI platforms and infrastructure to drive efficiency and growth for clients across multiple industries.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.